Dr. Martens' most consequential labor scandal was not a factory disaster but a brutal act of industrial retreat. After years of declining sales, AirWair International's revenue fell from $412 million in 1999 to $127 million in 2006, and the company came close to bankruptcy in 2003. On 1 April 2003, R. Griggs shut down its remaining British production, closed five factories and two shops, and transferred manufacturing to China and Thailand. More than 1,000 employees lost their jobs; the company's British workforce was reduced to only 20 people, almost entirely at headquarters. Annual production had fallen to roughly five million pairs, half the level reached during the brand's 1990s boom, making the closure a stark example of how a supposedly quintessentially British work boot could survive commercially by abandoning most of its domestic manufacturing base. Production later returned to the Cobbs Lane factory in Wollaston in 2004 for the premium Vintage line, but at a tiny scale: about 50 pairs per day in 2010, compared with the millions produced overseas. By 2018, only around one percent of the ten million pairs made annually were produced in the United Kingdom. The shift also generated a lasting authenticity and quality dispute: in 2019, The Guardian reported numerous customers alleging that newer Asian-made or post-acquisition boots failed sooner than older pairs, although Dr. Martens denied changing its materials or production methods and stated that only 0.5 percent of footwear was defective.
Preparing the daily feature…
AI concept artworkArchive Record · 2000s
The 2003 Dr. Martens Offshoring Collapse That Erased Its Northamptonshire Workforce
Dr. Martens / R. Griggs Group / 2000s
Dr. Martens' most consequential labor scandal was not a factory disaster but a brutal act of industrial retreat. After years of declining sales, AirWair International's revenue fell from $412 million in 1999 to $127 million in 2006, and the company came close to bankruptcy in 2003. On 1 April 2003, R. Griggs shut down its remaining British production, closed five factories and two shops, and transferred manufacturing to China and Thailand. More than 1,000 employees lost their jobs; the company's British workforce was reduced to only 20 people, almost entirely at headquarters. Annual production had fallen to roughly five million pairs, half the level reached during the brand's 1990s boom, making the closure a stark example of how a supposedly quintessentially British work boot could survive commercially by abandoning most of its domestic manufacturing base. Production later returned to the Cobbs Lane factory in Wollaston in 2004 for the premium Vintage line, but at a tiny scale: about 50 pairs per day in 2010, compared with the millions produced overseas. By 2018, only around one percent of the ten million pairs made annually were produced in the United Kingdom. The shift also generated a lasting authenticity and quality dispute: in 2019, The Guardian reported numerous customers alleging that newer Asian-made or post-acquisition boots failed sooner than older pairs, although Dr. Martens denied changing its materials or production methods and stated that only 0.5 percent of footwear was defective.
The daily editorial is currently unavailable. There’s still an entire archive to explore.
